To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
The fluctuations of ovarian hormones in the menstrual cycle (oestradiol, progesterone) are stimulated by luteinising hormone and follicle-stimulating hormone released from the anterior pituitary gland on stimulation from gonadotrophin-releasing hormone from the hypothalamus: this is the hypothalamopituitary gonadal axis. The role of these hormones is widespread and changes through puberty, pregnancy, the postnatal period, breastfeeding and perimenopause. The effect of these hormones on the brain and from external influences (e.g. trauma) on the hormonal circuitry identifies possible mechanisms behind hormonally related psychological symptoms and mental disorder. The relevance of the hypothalamopituitary gonadal axis for mental health professionals is explored, including pathological psychological responses to normal hormonal states, mental health symptoms related to hormonal disorders, and the impact of some psychiatric disorders and treatments on hormones.
This chapter provides the learner with the skills and knowledge for cases that involve a patient who comes in with undifferentiated right-sided back pain who is later found to have pyelonephritis. However, the case is complicated by the patient being a pregnant 30-year-old female who is allergic to penicillin and therefore the critical actions would be to determine her pregnancy and allergy, and then to prescribe the most appropriate antibiotics for a pregnant female.
Perinatal depression is a common disorder that can manifest during pregnancy and the postpartum period, severely affecting both the mother and the baby. Dietary factors have been associated with an increased risk of perinatal depression. We analyzed the association between adherence to certain dietary patterns before and during pregnancy and postpartum and perinatal depression. A scoping review of the available literature was conducted reporting the main findings following the PRISMA 2020 statement. The search strategy was last reproduced in December 2024 in MEDLINE, Web of Science and Scopus databases. The methodological quality of the studies was evaluated using the Newcastle-Ottawa Scale and the Revised Cochrane risk-of-bias tool for randomized trials. The protocol has been published on OSF (https://doi.org/10.17605/OSF.IO/AV8TP). 11 studies (6 cohort studies, 4 cross-sectional studies, and 1 randomized clinical trial) conducted in various countries were included in the mapping review. These studies evaluated the dietary intake of the participants at different times during the perinatal period and identified several dietary patterns. 9/11 studies showed a significant inverse association between adherence to the Mediterranean Diet or healthy patterns, characterized by high intake of vegetables, fruits, fish and seafood and perinatal depression. In contrast, 4/11 studies showed that adherence to Western dietary patterns and the consumption of ultra-processed foods was associated with higher risk of perinatal depression. Adherence to healthy dietary patterns may be negatively associated with perinatal depression. Conversely, Western diet and the intake of ultra-processed and pro-inflammatory foods are directly associated with a higher risk of perinatal depression.
This review aimed to summarise the nutrition education programs and interventions that have sought to improve maternal health outcomes. Pregnancy is often considered a “teachable moment” when mothers may be motivated to adopt positive behavioural changes, including improving their nutrition habits. Pregnancy nutrition education is the provision of information and guidance on optimal nutritional practices that aim to support a healthy pregnancy. This scoping review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Eight electronic databases were searched (Medline, Embase, CINAHL, Global Health, Scopus, PsycARTICLES, SocINDEX, Academic Search Complete) for studies reporting on nutrition education programs and interventions with pregnant women. Studies were included based on PICOS criteria, with no limitations on time and study design. Data were extracted and thematically analysed to identify the scope of diet, nutrition knowledge, and maternal outcomes included. This review includes 169 studies, which included various maternal outcomes, gestational weight gain; gestational diabetes mellitus, hypertensive disorders of pregnancy, and anaemia; dietary outcomes; nutritional status; and nutritional knowledge, attitudes, and/or behaviours. Significant positive results were observed for many health and dietary outcomes, with the exception of prevention of gestational diabetes and hypertensive disorders of pregnancy. A range of strategies have been used to deliver nutrition education. This inconsistency makes it challenging to summarize the key components of effective nutrition education and highlights the need for targeted approaches tailored to specific maternal outcomes.
The Healthy Eating Index (HEI) is widely used to assess diet quality, but certain contexts (e.g., pregnancy) may benefit from tailored versions. We evaluated whether the HEI’s current approach of assigning approximately equal weights to all components to compute the total score is appropriate when studying diet quality around conception. Data were from a U.S. prospective cohort of individuals who had not delivered a previous pregnancy past 20 weeks’ gestation (2010–2013, n=7882). Usual dietary intake around conception was estimated from food frequency questionnaires. Select adverse pregnancy outcomes (gestational diabetes, preeclampsia, preterm delivery, and small-for-gestational age birth) were abstracted from the medical record. We regressed each outcome on the 13 HEI-2015 component scores using SuperLearner, an ensemble machine learning method that combines predictions from multiple algorithms and avoids relying on parametric assumptions that characterize standard regression. We assessed the relative importance of each component using two permutation-based metrics: change in negative log likelihood (global influence) and absolute difference in the predicted probabilities (individual-level influence). Six of the 13 components (Greens and Beans, Saturated Fats, Total Protein Foods, Seafood and Plant Proteins, Fatty Acids, and Added Sugars) were important according to at least one metric for at least two of the four outcomes. In contrast, the Refined Grains component was not appreciably important for any outcome. These findings suggest that equal weighting of the HEI components may not be appropriate when evaluating diet quality for studies of pregnancy.
The aim is to examine the relationship between factors thought to potentially influence weight gain, such as sustainable nutrition (SN) behavior and plate clearing tendency (PCT) during pregnancy, and gestational weight gain (GWG). This cross-sectional correlational study was conducted on 340 women in the last trimester of pregnancy. Study data were collected through face-to-face interviews using a questionnaire form between October-December 2024. PCT is lower among younger women, those with low income and those with insufficient GWG (p<0.05). SN behaviors are higher in those who are older, have higher education levels, lower income and moderate physical activity (p<0.05). A negative correlation was found between food preference, a component of SN behaviors, and GWG (p<0.05). In the binary logistic regression model, higher pre-pregnancy BMI significantly increased the likelihood of excessive GWG (OR=1.49, 95% CI:1.332–1.665, p<0.001), whereas high physical activity was found to be protective against excessive GWG (OR=0.214, 95% CI:0.061–0.747, p=0.016). It was determined that pre-pregnancy BMI was higher and physical activity was lower in those with excessive GWG, in addition, food preference, one of the factors of SN behavior, affected weight gain. Food preference can be considered as a factor that may affect GWG.
Fe-deficiency anaemia is common during pregnancy and can lead to serious health consequences for mothers and babies. Antenatal Fe supplementation is associated with lower anaemia prevalence and improved pregnancy outcomes, and the WHO recommends daily oral Fe (30–60 mg) with folic acid (0·4 mg) during pregnancy. However, data on uptake and adherence in many low- and middle-income countries remain fragmented and outdated. We conducted a secondary analysis of Demographic and Health Surveys from sixty-nine low- and middle-income countries to assess uptake and adherence to Fe-containing supplements and explore associations with socio-demographic characteristics and antenatal care (ANC). Overall, 86 % of respondents reported receiving Fe supplements during pregnancy. Among these women, 46·1 % consumed ninety or more supplements, 23·3 % consumed 120 or more, and only 7·1 % consumed 180 or more. Higher education, wealth, and media access were strongly associated with increased odds of initiating supplementation (OR: 1·32; 95 % CI: 1·25, 1·38; OR: 1·29; 95 % CI: 1·20, 1·38; OR: 1·15; 95 % CI: 1·05, 1·26, respectively) and adhering to the regimen (OR: 1·16; 95 % CI: 1·12, 1·21; OR: 1·21; 95 % CI: 1·13, 1·30; OR: 1·14; 95 % CI: 1·08, 1·20, respectively). Early ANC attendance was also associated with higher supplement consumption. Country-specific ANC guidelines are needed to provide clear guidance on the timing and frequency of ANC attendance and supplementation.
Although lithium has been used effectively as a medication to treat bipolar and major depressive disorders, there are limited data defining lithium use patterns during pregnancy.
Aims
To investigate trends and patterns of lithium prescribing in the perinatal period (before, during and after pregnancy) among pregnancies in the UK.
Method
We conducted a population-based study using primary healthcare records from the Clinical Practice Research Datalink GOLD, analysing 752 112 pregnancies during the period 1995–2018. We assessed the prevalence and patterns of lithium prescriptions, including discontinuation, continuation and dosage. Maternal characteristics were defined for lithium non-users and users, and between those who continued and discontinued use.
Results
From 1995 to 2018, the prevalence of lithium prescribing per 10 000 pregnancies was 3.02 (95% CI: 2.64, 3.44) before pregnancy, 1.89 (95% CI: 1.59, 2.23) during pregnancy and 2.81 (95% CI: 2.44, 3.21) postpartum. Prescribing during pregnancy was low across the study period, with the most recent prevalence in 2018 of 1.03 (95% CI: 0.26, 4.11) per 10 000 pregnancies. Among 337 pregnancies with perinatal lithium prescribing, 48.4% involved a diagnosis of bipolar disorder. Of 227 pregnancies where lithium was prescribed preconception, 15.4% continued treatment throughout pregnancy; discontinuation occurred before pregnancy in 20.7%, and during second or third trimester in 30.8%; 33.0% followed other prescribing patterns. Women who discontinued lithium were more likely to be younger, have a body mass index ≥30 kg/m2, a diagnosis of bipolar disorder, a history of smoking and >10 primary care consultations in the 12 months preconception, compared with those who continued treatment.
Conclusions
Lithium prescribing during pregnancy in the UK is uncommon and discontinuation is frequent, particularly in the later stages of pregnancy. These findings highlight the need for proactive perinatal mental healthcare strategies and close clinical monitoring, to reduce unintentional first-trimester exposure while ensuring continuity of care for maternal mental health.
Providing physiologic support to a brain-dead pregnant decedent poses complex ethical, legal, and clinical challenges. Understanding these considerations is necessary to navigate complex discussion and provide appropriate medical care. We use a theoretical case to examine these considerations and outline a path forward.
To examine the association between household food insecurity (HFI) and low subjective well-being (SWB) among pregnant and postpartum women and determine whether these potential associations differed by maternal age and pregnancy status.
Design:
We conducted a secondary analysis of nationally representative cross-sectional data from women of reproductive age (15–49 years). HFI was measured using the Food Insecurity Experience Scale and categorised as none/mild, moderate or severe. Weighted multilevel logistic regression models were used to estimate OR and 95 % CI for the association between HFI and low levels of three SWB measures: happiness, life satisfaction and optimism. Analyses were stratified by age and pregnancy status.
Setting:
Data were drawn from the 2021 Nigeria Multiple Indicator Cluster Survey, Round 6.
Participants:
The analytic sample comprised 12 587 women who were pregnant at the time of the survey or within 24 months postpartum.
Results:
HFI was significantly associated with all three measures of SWB, although the magnitude of associations varied by outcome, even after adjusting for individual-, household-and community-level characteristics. Stratified analyses revealed heterogeneity in the associations between HFI and SWB by age and pregnancy status. Overall, HFI was associated with lower levels of happiness, life satisfaction and optimism among pregnant and postpartum women in Nigeria.
Conclusions:
Our findings demonstrate a negative association between HFI and SWB among pregnant and postpartum women in Nigeria. These associations were modified by maternal age and pregnancy status, suggesting that strategies to mitigate HFI should account for subgroup differences in order to effectively improve maternal well-being.
Edited by
Liz McDonald, East London NHS Foundation Trust,Roch Cantwell, Perinatal Mental Health Service and West of Scotland Mother & Baby Unit,Ian Jones, Cardiff University
Optimising women’s mental health at the time of conception, as a means of improving pregnancy outcomes, is of increasing interest. Women with pre-existing or new onset mental illness in the perinatal period, like those with pre-existing or new onset physical health conditions, are considered as high-risk pregnancies. Strategies to mitigate pre-conception risk factors are emerging from the evidence linking pre-conception health to pregnancy and birth outcomes. Yet data on the prevalence and effectiveness of psychiatric preconception health and care remain scant and inconclusive. The remits of pre-conception advice extend beyond the dilemma of prescribing psychotropic medication in childbearing women. Pre-conception counselling can inform women of the physiological and emotional changes occurring in pregnancy, explore expectations about parenthood and evaluate how the woman’s own experience of being parented may affect her parenting style. Equipping women and their partners with unbiased information through specialist advice will empower them to make an informed decision about their reproductive choices.
The aim of this chapter is to provide a best practice framework to guide pre-conception mental health advice to women with a mental illness. It will not detail the evidence on the association between the exposure of psychotropic medication and adverse outcomes.
Edited by
Liz McDonald, East London NHS Foundation Trust,Roch Cantwell, Perinatal Mental Health Service and West of Scotland Mother & Baby Unit,Ian Jones, Cardiff University
Depression is common in the perinatal period and is linked to negative consequences for pregnant and postpartum women and other childbearing individuals and their families, including the potential for long-term adverse outcomes in children. While the clinical approach to depression in pregnancy and postpartum is similar to that of the non-perinatal period in many ways, specific considerations include the role of reproductive hormones in the aetiology of the disorder, unique psychosocial stressors that may precipitate or perpetuate symptoms, and the safety of psychotropic medication in pregnancy and lactation. This chapter is an overview of depression in pregnancy and the first year postpartum, including a summary of its epidemiology, theories about aetiology, presentation, course, outcomes and an approach to management.
Edited by
Liz McDonald, East London NHS Foundation Trust,Roch Cantwell, Perinatal Mental Health Service and West of Scotland Mother & Baby Unit,Ian Jones, Cardiff University
Making decisions about prescribing medication for mental disorders in childbearing women is a task that may have profound and long-lasting implications for a mother and her family, and it is important that prescribers have access to up-to-date summaries and interpretations of research that examines how safe these medications are in pregnancy and lactation.
Because it is not possible to test a drug’s reproductive safety in randomised controlled trials, research has to rely on less rigorous study designs. The inherent difficulties and other methodological problems have meant that interpretation of the evidence has often been difficult. However, the volume and quality of research has dramatically increased in recent years. Current findings concerning antidepressant, antipsychotic and mood-stabilising medication during pregnancy and lactation are summarised in this chapter, and recommendations for clinical practice are made referring to published guidelines where they are available.
Edited by
Liz McDonald, East London NHS Foundation Trust,Roch Cantwell, Perinatal Mental Health Service and West of Scotland Mother & Baby Unit,Ian Jones, Cardiff University
This chapter is an essential guide to recognising and treating ADHD in the perinatal period, an increasingly common scenario which specialist community and inpatient perinatal services face. We explore issues specific to assessing and treating women with ADHD. The features of how the disorder is classified are discussed, including information on how ADHD may present differently in women. The challenges of identifying ADHD in females are considered along with common comorbidities. A summary of guidance on treating this disorder in adults is included, with information on pharmacological and non-pharmacological treatment options. An outline of the essential investigations required before initiating medication for a woman is provided, along with details on the necessary ongoing physical health monitoring. Both stimulant and non-stimulant medicines are discussed with details on the various formulations available in the UK and practical tips on prescribing in the perinatal period. Specific issues to explore at follow-up are outlined. Special consideration is given to recognising and treating ADHD in the perinatal period. This includes during the pre-conceptual period, prescribing in pregnancy and the postnatal period including breastfeeding. The impact of ADHD on parenting is also considered. This is essential reading on a commonly misunderstood disorder for all perinatal clinicians.
Edited by
Liz McDonald, East London NHS Foundation Trust,Roch Cantwell, Perinatal Mental Health Service and West of Scotland Mother & Baby Unit,Ian Jones, Cardiff University
Millions of women and girls worldwide experience violence. Violence against women and girls takes many forms, including physical, emotional and sexual violence and abuse, which is associated with a range of adverse impacts on women, their families and society as a whole. Health professionals supporting women during the perinatal period should assess the risks posed by exposure to previous or current violence and how this may affect them during pregnancy. As an important risk factor in a woman’s mental health presentation, psychiatrists working with pregnant and postpartum women should consider the presence of violence in their formulation; it can increase the risk of anxiety, depression and post-traumatic stress disorder (PTSD). Domestic violence and abuse increase the risk of domestic homicide and may play a role in many perinatal suicides. Sensitive assessment and effective management of women exposed to violence can improve engagement with mental health services and response to treatment.
Edited by
Liz McDonald, East London NHS Foundation Trust,Roch Cantwell, Perinatal Mental Health Service and West of Scotland Mother & Baby Unit,Ian Jones, Cardiff University
Pregnancies among individuals with schizophrenia spectrum disorders have increased in recent years. In the perinatal period, individuals with schizophrenia spectrum disorders are faced with managing the unique effects of their symptoms on pregnancy and parenting, which fluctuate through the perinatal period with the early postpartum being a high-risk time for relapse. Their pregnancies are also associated with a range of adverse pregnancy, neonatal and long-term child outcomes, the risk for which may be related in part to modifiable factors. Prejudice, discrimination and subsequent isolation of perinatal individuals with schizophrenia spectrum disorders may limit health care and social support opportunities in this group, further exacerbating the risk for negative outcomes. These issues underscore the need for comprehensive management approaches including attention to pre-conception health, medication management during pregnancy and postpartum, and multifaceted support for the parent and family. This chapter is an overview of schizophrenia spectrum disorders in the perinatal period, including a summary of the epidemiology, clinical presentation, course, outcomes and management.
Gestational weight gain (GWG) can be defined as the total weight gained throughout pregnancy and is required for healthy fetal growth; however, gaining excessive weight during pregnancy has been linked with several adverse effects. This review aims to consider the evidence on weight management during pregnancy, with a focus on the key challenges surrounding GWG and the practical considerations related to assessing weight changes. It is estimated that nearly 50% of women gain excessive weight during pregnancy; nevertheless, this can be difficult to quantify due to the lack of global consensus on recommended GWG guidelines. Currently, there are no GWG guidelines in the UK and Ireland, as reiterated in the recent National Institute for Health and Care Excellence guidelines, due to the lack of evidence about what the optimal total weight change in pregnancy should be. This is further complicated by the conflicting results of interventions aimed at preventing excessive GWG and their resultant inconsistent effects on adverse pregnancy outcomes. Accurate calculation of GWG requires measurement of pre-pregnancy weight and weight prior to the onset of labour. However, several practical considerations are associated with obtaining these weights, as in practice, estimated or self-recalled weights are often used as an alternate, thereby introducing variability into the measurement of GWG and the potential for inaccuracies in analysis. These limitations highlight the need for a more uniform approach in assessing GWG. The WHO is in the process of developing global GWG standards, and this could potentially establish a uniform gold standard for assessing GWG and reintroduce routine weighing.
Fasting during pregnancy is a widespread practice in Muslim communities, yet its health implications remain poorly understood. A lack of conceptual frameworks and limited understanding of the characteristics of women who fast during pregnancy have hindered research in this area. This study examines the differences in several nutritional biomarkers between women who fasted and those who did not and identifies factors associated with fasting behaviour. We analysed data from the Kuwait Birth Cohort in which information on fasting, sociodemographic characteristics and health behaviours was collected via structured interviews between 2017 and 2021. Clinical and laboratory data were extracted from medical records. Predictors of fasting were identified using Least Absolute Shrinkage and Selection Operator (LASSO) logistic regression with 5-fold cross-validation, followed by Poisson regression with robust standard errors. Among 1087 women with available data, 581 (53·4 %; 95 % CI 50·4 %, 56·4 %) reported fasting during pregnancy (19·5 % in the first trimester, 25·1 % in the second and 10·1 % in the third). Women who fasted had significantly lower levels of ferritin (P = 0·048), vitamin B12 (P = 0·001), erythrocytes folate (P < 0·001), 25-hydroxyvitamin D (P = 0·002) and vitamin D binding protein (P = 0·011), but higher parathyroid hormone (P = 0·011). Predictive models based on sociodemographic and clinical factors showed limited predictive ability. This study indicates that fasting during pregnancy is a common practice among women in Kuwait and is associated with lower levels of key nutrients such as vitamin D, RBC folate and vitamin B12. Fasting during pregnancy appears to be driven more by personal, religious and cultural influences than by identifiable clinical or sociodemographic characteristics.
This study examined the impact of maternal undernutrition during gestation and/or lactation on neonatal immune indices. From day 10 of gestation to term, pregnant rats received either ad libitum (AdLib) feeding or 50% food restriction (FR). After birth, pups were either nursed by their own dams or cross-fostered, resulting in three groups (n = 6 per group): a control group with AdLib feeding throughout (AdLib/AdLib), a group with FR only during gestation (FR/AdLib), and a group with FR during both gestation and lactation (FR/FR). At day of life 1 and at three weeks of age, spleen and thymus weights, as well as basal and lipopolysaccharide (LPS)-stimulated TNF levels and white blood cell indices, were measured in male offspring. At day of life 1, immunological indices were similar among groups. By three weeks, monocyte percentage was significantly decreased in FR/FR compared with AdLib/AdLib (1.6 ± 0.5% vs. 3.1 ± 0.4%). Relative spleen weight (adjusted for body weight) was also significantly lower in FR/FR compared with both AdLib/AdLib and FR/AdLib. Following LPS administration, TNF-α levels were reduced in FR/FR compared with FR/AdLib and AdLib/AdLib (206 ± 28 vs. 511 ± 91 and 484 ± 59 pg/ml, respectively; P < 0.05). Moreover, in FR/FR offspring, monocyte (5.4 ± 1.1% vs. 2.0 ± 0.6% and 2.0 ± 0.7%) and neutrophil (50.6 ± 5.5% vs. 17.2 ± 2.4% and 20.0 ± 4.2%) percentages were significantly increased, while lymphocyte percentage (43.2 ± 5.9% vs. 80.0 ± 2.4% and 77.2 ± 4.4%) was decreased compared with FR/AdLib and AdLib/AdLib. These findings suggest that undernutrition during both prenatal and postnatal periods can attenuate neonatal immunity by decreasing basal monocyte counts and impairing cytokine responses.
The planetary health diet (PHD) is a mostly plant-based diet that aims to optimise human health while minimising the environmental impact of food production. Limited data exist on whether the PHD fulfils key nutritional requirements during pregnancy. This research aimed to examine the PHD in early pregnancy and how it aligns with daily nutrient intake and European Food Safety Authority (EFSA) dietary guidelines. Pregnant women (n 678) from two Irish cohorts (ROLO and MicrobeMom) were analysed, and PHD index (PHDI) scores were assigned based on data from 3-d food diaries. Women were dichotomised by the median score to create a ‘High PHDI’ (> 88·99) and a ‘Low PHDI’ group (≤ 88·99). Differences in nutrient intakes and adherence to dietary guidelines between ‘High’ and ‘Low’ PHDI groups were explored. Compared with those with a ‘Low’ score, those with a ‘High’ PHDI score reported higher intakes of dietary fibre (g/d) (17·32 (13·39, 21·08) v. 21·74 (18·28, 25·88), P < 0·001), Fe (mg/d) (10·48 (8·48, 12·82) v. 12·06 (9·48, 14·60), P < 0·001), folate (µg dietary folate equivalent per d) (250·73 (193·88, 312·45) v. 279·57 (219·43, 356·81), P < 0·001) and Ca (mg/d) (837·75 (695·36, 1056·72) v. 956·57 (751·84, 1155·03), P < 0·001). A greater proportion of women in the ‘High PHDI’ group met EFSA recommendations for dietary fibre intake (10·3 % v. 28·9 %, P < 0·001). The PHD may support maternal nutritional adequacy in pregnancy while promoting environmental sustainability. Our findings provide valuable insights that can inform future dietary recommendations for pregnancy, contributing to both maternal health and planetary well-being.